Eiffel names CEO as executive director
Monday, 02 June, 2003
Eiffel Technologies' CEO Christine Cussen has joined the company's board as an executive director.
Formerly managing director of AstraZeneca Pharmaceuticals, Cussen joined Melbourne-based Eiffel in October 2000 to oversee the development and commercialisation of the company's supercritical fluid technologies.
"She has brought strong professional marketing and management expertise to Eiffel at a time when we were seeking to increase the exposure of our technologies to our customer base and international pharmaceutical companies worldwide. She is a very valued employee and we recognise that she will make a significant contribution at Board level to the success of the company," said chairman Tom Hartigan.
Common arthritis drug also lowers blood pressure
Scientists have known for a while that methotrexate helps with inflammation, but it may also help...
AI enables precise gene editing
A newly developed tool utilises AI to predict how cells repair their DNA after it is cut by gene...
Shingles vaccine may reduce risk of heart attack and stroke
Vaccination with either the recombinant herpes zoster vaccine or the live-attenuated zoster...
